Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Awarded to (8 suppliers)
| Award value: | £25,881,000 |
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 1/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 1/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 1/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Not specified |
| Release Date: | 26 November 2025 |
| Application Deadline: | — |
| Contract Start Date: | — |
| Contract End Date: | — |
| Contract Duration: | NaN years |
| Procurement ID (OCID): | ocds-h6vhtk-05936a |
| Notice Reference: | 077377-2025 |
All 4 notices for this procurement, oldest first.
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
View Original Notice
Access the full notice on the official portal
| Award decision date: | — |
| Award status: | Pending |